Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$3.57M
3 trades · 1 insiders
Net · 90d
$-3.57M
Insiders on file
14
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Smith Nicholas Conrad | PRESIDENT AND CFO | 29 | $125.6K | $3.57M | 2026-10-02 |
| Miller Andrew Craig | Director | 1 | $0 | $0 | 2026-05-27 |
| Etkin Amit | PRESIDENT AND CEO | 17 | $50.0K | $0 | 2026-05-14 |
| Manji Husseini | Director | 6 | $0 | $0 | 2026-05-12 |
| York Gwill | Director | 8 | $0 | $0 | 2026-05-12 |
| Cox Christopher Nixon | Director | 10 | $0 | $0 | 2026-05-12 |
| Sanchez Ramiro | Director | 4 | $0 | $0 | 2026-05-12 |
| Dreyfus Andrew | Director | 3 | $0 | $0 | 2026-05-12 |
| Savitz Adam | CHIEF MEDICAL OFFICER | 19 | $462.8K | $0 | 2026-02-11 |
| Hanley Jr. Michael Conick | Chief Operating Officer | 9 | $0 | $0 | 2026-02-11 |
| Radhakrishnan Maha | Director | 2 | $0 | $0 | 2024-03-08 |
| Chen Po Yu (Jeff) | Director | 6 | $0 | $0 | 2024-02-06 |
| Apeiron Investment Group Ltd. | Other | 6 | $0 | $0 | 2024-02-06 |
| Alpha Wave Global, LP | 10% Owner | 5 | $9.60M | $0 | 2024-02-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise deriv | 2026-10-02 | 2026-10-05 | 55,000 | — | $0 | 57,405 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise | 2026-10-02 | 2026-10-05 | 55,000 | $2.32 | $127.6K | 79,060 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise deriv | 2026-09-30 | 2026-10-01 | 24,056 | — | $0 | 121,818 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | S Sale | 2026-09-30 | 2026-10-01 | 886 | $26.87 | $23.8K | 24,060 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | S Sale | 2026-09-30 | 2026-10-01 | 23,170 | $25.78 | $597.3K | 24,946 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise | 2026-09-30 | 2026-10-01 | 24,056 | $2.35 | $56.5K | 48,116 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise deriv | 2026-09-29 | 2026-10-01 | 54,375 | — | $0 | 35,625 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise deriv | 2026-09-29 | 2026-10-01 | 56,455 | — | $0 | 145,874 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | S Sale | 2026-09-29 | 2026-10-01 | 110,830 | $26.58 | $2.95M | 24,060 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise | 2026-09-29 | 2026-10-01 | 54,375 | $2.35 | $127.8K | 134,890 | SEC↗ |
| Smith Nicholas Conrad | PRESIDENT AND CFO | M Exercise | 2026-09-29 | 2026-10-01 | 56,455 | $2.35 | $132.7K | 80,515 | SEC↗ |
| Miller Andrew Craig | Director | A Award deriv | 2026-05-27 | 2026-05-29 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | G Gift | 2026-05-14 | 2026-05-15 | 400,000 | — | $0 | 833,949 | SEC↗ |
| York Gwill | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| Dreyfus Andrew | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| Manji Husseini | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| Cox Christopher Nixon | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | F Tax w/h | 2026-03-01 | 2026-03-03 | 2,806 | $19.69 | $55.3K | 24,060 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | F Tax w/h | 2026-03-01 | 2026-03-03 | 6,227 | $19.69 | $122.6K | 1,233,949 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A Award deriv | 2026-02-11 | 2026-02-13 | 131,000 | — | $0 | 131,000 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2026-02-11 | 2026-02-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2026-02-11 | 2026-02-13 | 124,000 | — | $0 | 124,000 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2026-02-11 | 2026-02-13 | 306,000 | — | $0 | 306,000 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 3,806 | $11.82 | $45.0K | 3,806 | SEC↗ |
| Manji Husseini | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 4,228 | $11.82 | $50.0K | 4,228 | SEC↗ |
| Cox Christopher Nixon | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 7,189 | $11.82 | $85.0K | 7,189 | SEC↗ |
| York Gwill | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 5,243 | $11.82 | $62.0K | 5,243 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2025-08-12 | 2025-08-14 | 30,574 | — | $0 | 30,574 | SEC↗ |
| Sanchez Ramiro | Director | A Award deriv | 2025-08-12 | 2025-08-14 | 3,928 | $2.21 | $8.7K | 3,928 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | D To issuer deriv | 2025-07-03 | 2025-07-08 | 135,000 | — | $0 | 0 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2025-07-03 | 2025-07-08 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | D To issuer deriv | 2025-07-03 | 2025-07-08 | 90,000 | — | $0 | 0 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2025-07-03 | 2025-07-08 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | D To issuer deriv | 2025-07-03 | 2025-07-08 | 202,329 | — | $0 | 0 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2025-07-03 | 2025-07-08 | 202,329 | — | $0 | 202,329 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | D To issuer deriv | 2025-07-03 | 2025-07-08 | 33,833 | — | $0 | 0 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2025-07-03 | 2025-07-08 | 33,833 | — | $0 | 33,833 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2025-07-03 | 2025-07-08 | 44,962 | — | $0 | 44,962 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | D To issuer deriv | 2025-07-03 | 2025-07-08 | 44,962 | — | $0 | 0 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2025-07-03 | 2025-07-08 | 34,620 | — | $0 | 34,620 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | D To issuer deriv | 2025-07-03 | 2025-07-08 | 34,620 | — | $0 | 0 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2025-07-03 | 2025-07-08 | 247,290 | — | $0 | 247,290 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | D To issuer deriv | 2025-07-03 | 2025-07-08 | 247,290 | — | $0 | 0 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2025-07-03 | 2025-07-08 | 223,000 | — | $0 | 223,000 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | D To issuer deriv | 2025-07-03 | 2025-07-08 | 223,000 | — | $0 | 0 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2025-07-03 | 2025-07-08 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | D To issuer deriv | 2025-07-03 | 2025-07-08 | 215,000 | — | $0 | 0 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 22,481 | — | $0 | 22,481 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 22,481 | — | $0 | 0 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 33,008 | — | $0 | 33,008 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 33,008 | — | $0 | 0 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 123,645 | — | $0 | 123,645 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 123,645 | — | $0 | 0 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 73,000 | — | $0 | 73,000 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 73,000 | — | $0 | 0 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 76,000 | — | $0 | 76,000 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 76,000 | — | $0 | 0 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 125,000 | — | $0 | 0 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 188,000 | — | $0 | 0 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A Award deriv | 2025-07-03 | 2025-07-08 | 188,000 | — | $0 | 188,000 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | D To issuer deriv | 2025-07-03 | 2025-07-08 | 8,000 | — | $0 | 0 | SEC↗ |
| York Gwill | Director | A Award deriv | 2025-05-13 | 2025-05-15 | 15,287 | — | $0 | 15,287 | SEC↗ |
| Dreyfus Andrew | Director | A Award deriv | 2025-05-13 | 2025-05-15 | 15,287 | — | $0 | 15,287 | SEC↗ |
| Cox Christopher Nixon | Director | A Award deriv | 2025-05-13 | 2025-05-15 | 15,287 | — | $0 | 15,287 | SEC↗ |
| Manji Husseini | Director | A Award deriv | 2025-05-13 | 2025-05-15 | 15,287 | — | $0 | 15,287 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2025-02-05 | 2025-02-07 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-05 | 2025-02-07 | 76,000 | — | $0 | 76,000 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & C | A Award deriv | 2025-02-05 | 2025-02-07 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A Award deriv | 2025-02-05 | 2025-02-07 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Cox Christopher Nixon | Director | A Award deriv | 2025-01-02 | 2025-01-06 | 25,236 | $3.17 | $80.0K | 25,236 | SEC↗ |
| Manji Husseini | Director | A Award deriv | 2025-01-02 | 2025-01-06 | 14,195 | $3.17 | $45.0K | 14,195 | SEC↗ |
| York Gwill | Director | A Award deriv | 2025-01-02 | 2025-01-06 | 19,558 | $3.17 | $62.0K | 19,558 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | P Buy | 2024-07-10 | 2024-07-11 | 2,931 | $13.22 | $38.7K | 39,851 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | P Buy | 2024-07-09 | 2024-07-11 | 1,388 | $13.15 | $18.3K | 36,920 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | P Buy | 2024-07-09 | 2024-07-11 | 10,681 | $12.53 | $133.8K | 35,532 | SEC↗ |
| Hanley Jr. Michael Conick | Chief Operating Officer | A Award deriv | 2024-05-20 | 2024-05-22 | 188,000 | — | $0 | 188,000 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P Buy | 2024-03-28 | 2024-04-01 | 4,550 | $16.56 | $75.3K | 26,866 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P Buy | 2024-03-28 | 2024-04-01 | 1,600 | $15.80 | $25.3K | 22,316 | SEC↗ |
| Radhakrishnan Maha | Director | A Award deriv | 2024-03-08 | 2024-03-12 | 1,590 | $10.21 | $16.2K | 1,590 | SEC↗ |
| Radhakrishnan Maha | Director | A Award deriv | 2024-03-08 | 2024-03-12 | 30,574 | — | $0 | 30,574 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award deriv | 2024-03-01 | 2024-03-05 | 223,000 | — | $0 | 223,000 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-03-01 | 2024-03-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | A Award deriv | 2024-03-01 | 2024-03-05 | 73,000 | — | $0 | 73,000 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | A Award | 2024-03-01 | 2024-03-05 | 34,711 | — | $0 | 1,240,176 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | A Award | 2024-03-01 | 2024-03-05 | 19,153 | — | $0 | 20,716 | SEC↗ |
| Chen Po Yu (Jeff) | Director | C Conversion deriv | 2024-02-06 | 2024-02-07 | 18,794 | — | $0 | 0 | SEC↗ |
| Chen Po Yu (Jeff) | Director | C Conversion deriv | 2024-02-06 | 2024-02-07 | 83,333 | — | $0 | 0 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | C Conversion deriv | 2024-02-06 | 2024-02-07 | 25,000 | — | $0 | 0 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | C Conversion deriv | 2024-02-06 | 2024-02-07 | 16,666 | — | $0 | 0 | SEC↗ |
| Cox Christopher Nixon | Director | C Conversion deriv | 2024-02-06 | 2024-02-07 | 1,250,000 | — | $0 | 0 | SEC↗ |
| Cox Christopher Nixon | Director | C Conversion deriv | 2024-02-06 | 2024-02-07 | 281,917 | — | $0 | 0 | SEC↗ |
| York Gwill | Director | C Conversion deriv | 2024-02-06 | 2024-02-07 | 53,196 | — | $0 | 0 | SEC↗ |
| Alpha Wave Global, LP | 10% Owner | C Conversion deriv | 2024-02-06 | 2024-02-08 | 1,144,763 | — | $0 | 0 | SEC↗ |
| Alpha Wave Global, LP | 10% Owner | C Conversion deriv | 2024-02-06 | 2024-02-08 | 1,962,995 | — | $0 | 0 | SEC↗ |
| Apeiron Investment Group Ltd. | Other | C Conversion deriv | 2024-02-06 | 2024-03-06 | 1,063,918 | — | $0 | 0 | SEC↗ |
| Apeiron Investment Group Ltd. | Other | C Conversion deriv | 2024-02-06 | 2024-03-06 | 444,561 | — | $0 | 0 | SEC↗ |
| Apeiron Investment Group Ltd. | Other | C Conversion deriv | 2024-02-06 | 2024-03-06 | 416,665 | — | $0 | 0 | SEC↗ |
| Apeiron Investment Group Ltd. | Other | C Conversion deriv | 2024-02-06 | 2024-03-06 | 406,072 | — | $0 | 0 | SEC↗ |
| Chen Po Yu (Jeff) | Director | C Conversion | 2024-02-06 | 2024-02-07 | 39,259 | — | $0 | 39,259 | SEC↗ |
| Chen Po Yu (Jeff) | Director | C Conversion | 2024-02-06 | 2024-02-07 | 8,450 | — | $0 | 47,709 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | C Conversion | 2024-02-06 | 2024-02-07 | 11,777 | — | $0 | 1,202,340 | SEC↗ |
| Etkin Amit | PRESIDENT AND CEO | P Buy | 2024-02-06 | 2024-02-07 | 3,125 | $16.00 | $50.0K | 1,205,465 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | C Conversion | 2024-02-06 | 2024-02-07 | 7,851 | — | $0 | 7,851 | SEC↗ |
| Savitz Adam | CHIEF MEDICAL OFFICER | P Buy | 2024-02-06 | 2024-02-07 | 17,000 | $16.00 | $272.0K | 24,851 | SEC↗ |
| Cox Christopher Nixon | Director | C Conversion | 2024-02-06 | 2024-02-07 | 588,898 | — | $0 | 588,898 | SEC↗ |
| Cox Christopher Nixon | Director | C Conversion | 2024-02-06 | 2024-02-07 | 126,755 | — | $0 | 715,653 | SEC↗ |
| Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P Buy | 2024-02-06 | 2024-02-07 | 1,563 | $16.00 | $25.0K | 1,563 | SEC↗ |
| York Gwill | Director | C Conversion | 2024-02-06 | 2024-02-07 | 23,917 | — | $0 | 23,917 | SEC↗ |
| Alpha Wave Global, LP | 10% Owner | C Conversion | 2024-02-06 | 2024-02-08 | 1,962,995 | — | $0 | 1,962,995 | SEC↗ |
| Alpha Wave Global, LP | 10% Owner | C Conversion | 2024-02-06 | 2024-02-08 | 1,144,762 | — | $0 | 3,107,757 | SEC↗ |
| Alpha Wave Global, LP | 10% Owner | P Buy | 2024-02-06 | 2024-02-08 | 600,000 | $16.00 | $9.60M | 3,707,757 | SEC↗ |
| Apeiron Investment Group Ltd. | Other | C Conversion | 2024-02-06 | 2024-03-06 | 251,881 | — | $0 | 251,881 | SEC↗ |
| Apeiron Investment Group Ltd. | Other | C Conversion | 2024-02-06 | 2024-03-06 | 674,658 | — | $0 | 674,658 | SEC↗ |
| Dreyfus Andrew | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 30,574 | — | $0 | 30,574 | SEC↗ |
| Cox Christopher Nixon | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 30,574 | — | $0 | 30,574 | SEC↗ |
| Cox Christopher Nixon | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 4,623 | $11.88 | $54.9K | 4,623 | SEC↗ |
| Chen Po Yu (Jeff) | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 1,540 | $11.88 | $18.3K | 1,540 | SEC↗ |
| Chen Po Yu (Jeff) | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 30,574 | — | $0 | 30,574 | SEC↗ |
| Manji Husseini | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 30,574 | — | $0 | 30,574 | SEC↗ |
| Manji Husseini | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 3,083 | $11.88 | $36.6K | 3,083 | SEC↗ |
| York Gwill | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 30,574 | — | $0 | 30,574 | SEC↗ |
| York Gwill | Director | A Award deriv | 2024-02-01 | 2024-02-05 | 3,083 | $11.88 | $36.6K | 3,083 | SEC↗ |